UY28592A1 - Derivados de 2-fenilbenzofurano, un procedimiento para su preparación y su uso - Google Patents
Derivados de 2-fenilbenzofurano, un procedimiento para su preparación y su usoInfo
- Publication number
- UY28592A1 UY28592A1 UY28592A UY28592A UY28592A1 UY 28592 A1 UY28592 A1 UY 28592A1 UY 28592 A UY28592 A UY 28592A UY 28592 A UY28592 A UY 28592A UY 28592 A1 UY28592 A1 UY 28592A1
- Authority
- UY
- Uruguay
- Prior art keywords
- phenylbenzofuran
- derivatives
- procedure
- preparation
- phenylbenzofurans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/66—Aspergillus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Furan Compounds (AREA)
Abstract
La presente invención se refiere a 2-fenilbenzofuranos del tipo de la fórmula (I) que se forman durante la fermentación por el microorganismo Aspergillus flavipes ST003878 (DSM 15290), a un procedimiento para prepararlos y a su uso como productos farmacéuticos para el tratamiento y/o la profilaxia de enfermedades infecciosas bacterianas o micosis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10351315A DE10351315A1 (de) | 2003-10-31 | 2003-10-31 | 2-Phenyl-benzofuran-Derivate, Verfahren zur ihrer Herstellung und ihre Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
UY28592A1 true UY28592A1 (es) | 2005-05-31 |
Family
ID=34584854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY28592A UY28592A1 (es) | 2003-10-31 | 2004-10-29 | Derivados de 2-fenilbenzofurano, un procedimiento para su preparación y su uso |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1689731B1 (es) |
JP (1) | JP4758905B2 (es) |
KR (1) | KR20060110873A (es) |
CN (1) | CN1875012A (es) |
AR (1) | AR046212A1 (es) |
AT (1) | ATE356120T1 (es) |
AU (1) | AU2004288737A1 (es) |
BR (1) | BRPI0415978A (es) |
CA (1) | CA2543629A1 (es) |
DE (2) | DE10351315A1 (es) |
IL (1) | IL174975A0 (es) |
MX (1) | MXPA06004082A (es) |
UY (1) | UY28592A1 (es) |
WO (1) | WO2005047275A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2164478A2 (en) * | 2007-06-08 | 2010-03-24 | University of Copenhagen | Pdz domain modulators |
CN101914080B (zh) * | 2010-08-05 | 2012-10-03 | 上海交通大学 | 苯并呋喃-3-甲酮取代苯基类化合物及其制备和应用 |
CN103242273B (zh) | 2012-02-09 | 2015-06-03 | 中国科学院上海药物研究所 | 2-芳基苯并呋喃-7-甲酰胺类化合物、其制备方法及用途 |
US20150322094A1 (en) * | 2012-09-05 | 2015-11-12 | Bayer Cropscience Ag | Use of substituted 2,3-dihydro-1-benzofuran-4-carboxylic acids or salts thereof as active substances against abiotic plant stress |
EP3360549A1 (en) | 2017-02-14 | 2018-08-15 | Rheinische Friedrich-Wilhelms-Universität Bonn | Small molecule therapeutics for treating metachromatic leukodystrophy |
CN115943957B (zh) * | 2022-07-18 | 2024-01-26 | 北京景霁智惠科技有限公司 | Tbfc在制备防治细菌性病害的药物中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6143182A (ja) * | 1984-08-03 | 1986-03-01 | Ss Pharmaceut Co Ltd | 新規な抗生物質ss19508d及びその製造法 |
JP2955395B2 (ja) * | 1990-12-14 | 1999-10-04 | メルシャン株式会社 | 抗真菌性物質Mer−WF5027及びその製造法 |
WO2002010156A1 (en) * | 2000-07-29 | 2002-02-07 | Arpida Ag | Benzofuran derivatives and their use as antibacterial agents |
GB2386891A (en) * | 2002-03-28 | 2003-10-01 | Pantherix Ltd | Antibacterial benzofuran-2H-3-ones |
WO2003097815A2 (en) * | 2002-05-17 | 2003-11-27 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Molecular identification of aspergillus species |
-
2003
- 2003-10-31 DE DE10351315A patent/DE10351315A1/de not_active Withdrawn
-
2004
- 2004-10-16 WO PCT/EP2004/011695 patent/WO2005047275A1/de active IP Right Grant
- 2004-10-16 AU AU2004288737A patent/AU2004288737A1/en not_active Abandoned
- 2004-10-16 BR BRPI0415978-0A patent/BRPI0415978A/pt not_active Application Discontinuation
- 2004-10-16 JP JP2006537126A patent/JP4758905B2/ja not_active Expired - Fee Related
- 2004-10-16 KR KR1020067008283A patent/KR20060110873A/ko not_active Application Discontinuation
- 2004-10-16 DE DE502004003187T patent/DE502004003187D1/de not_active Expired - Lifetime
- 2004-10-16 EP EP04790531A patent/EP1689731B1/de not_active Expired - Lifetime
- 2004-10-16 MX MXPA06004082A patent/MXPA06004082A/es not_active Application Discontinuation
- 2004-10-16 AT AT04790531T patent/ATE356120T1/de not_active IP Right Cessation
- 2004-10-16 CN CNA2004800326034A patent/CN1875012A/zh active Pending
- 2004-10-16 CA CA002543629A patent/CA2543629A1/en not_active Abandoned
- 2004-10-28 AR ARP040103934A patent/AR046212A1/es unknown
- 2004-10-29 UY UY28592A patent/UY28592A1/es unknown
-
2006
- 2006-04-11 IL IL174975A patent/IL174975A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1689731A1 (de) | 2006-08-16 |
MXPA06004082A (es) | 2006-06-27 |
CN1875012A (zh) | 2006-12-06 |
BRPI0415978A (pt) | 2007-01-23 |
ATE356120T1 (de) | 2007-03-15 |
JP4758905B2 (ja) | 2011-08-31 |
KR20060110873A (ko) | 2006-10-25 |
EP1689731B1 (de) | 2007-03-07 |
DE10351315A1 (de) | 2005-06-16 |
IL174975A0 (en) | 2006-08-20 |
AU2004288737A1 (en) | 2005-05-26 |
JP2007512238A (ja) | 2007-05-17 |
DE502004003187D1 (de) | 2007-04-19 |
CA2543629A1 (en) | 2005-05-26 |
WO2005047275A1 (de) | 2005-05-26 |
AR046212A1 (es) | 2005-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1113766T1 (el) | Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων | |
CU23105A3 (es) | DERIVADOS NOVEDOSOS DEL áCIDO AMINODICARBOXILICO CON PROPIEDADES FARMACéUTICAS | |
PH12020551578A1 (en) | Modulators of methyl modifying enzymes, compositions and uses thereof | |
CY1120974T1 (el) | Ετεροκυκλικες ενωσεις, φαρμακα που περιεχουν τις αναφερομενες ενωσεις, χρηση αυτων και διαδικασιες για την παραγωγη τους | |
CO2022001094A2 (es) | Pirrolo[2,3-b]pirazinas como inhibidores de hpk1 y uso de las mismas | |
CU23366B7 (es) | Oxazolidinonas substituidas para terapia de combinación | |
ECSP056019A (es) | 2,4-di(fenilamino)pirimidinas útiles en el tratamiento de enfermedades neoplásicas, trastornos inflamatorios y del sistema inmune | |
PH12020552017A1 (en) | 2,3-dihydro-1h-pyrrolizine-7-formamide derivative and application thereof | |
DOP2006000017A (es) | Pirazolopiridinas y sales de las mismas, una composición farmaceútica que comprende dichos compuestos, un método para prepararlos y su uso | |
ECSP11010992A (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales | |
GEP20186938B (en) | Indolizine derivatives as phoshoinositide 3-kinases inhibitors | |
CY1117504T1 (el) | Παραγωγα 1-βενζυλ-3-υδροξυμεθυλινδαζολης και η χρηση τους στη θεραπευτικη αντιμετωπιση νοσων που βασιζονται στην εκφραση των mcp-1, και cx3cr1 | |
WO2022038365A3 (en) | Fumarate derivatives and their medical use | |
UY31133A1 (es) | "oxazolidinonas sustituidas y su uso" | |
SI1594885T1 (sl) | Zdravilo za inhibiranje rasti tumorjev | |
UY29358A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
BRPI0516677A (pt) | nonadepsipeptìdeos acilados como derivados de lysobactin | |
UY28115A1 (es) | Derivados del acido isoftalico | |
UY28592A1 (es) | Derivados de 2-fenilbenzofurano, un procedimiento para su preparación y su uso | |
BR112021015638A2 (pt) | Métodos, composições contendo bactéria produtora de bacileno ou preparações das mesmas | |
ECSP088472A (es) | Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento | |
AU2020256283A8 (en) | Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof | |
BR0311801A (pt) | Composição de imidazol, método para produção do mesmo, composição farmacêutica, embalagem comercial, método para a profilaxia ou tratamento de doenças, método para erradicar helicobacter pylori de um animal infectado com helicobacter pylori, e, uso de um composto | |
AR081514A1 (es) | El compuesto 4-[etil(dimetil)amonio]butanoato, el metodo para la preparacion del mismo y el uso en el tratamiento de la enfermedad cardiovascular | |
UY27733A1 (es) | Derivados de ciclopenteno. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DESI | Application deemed to be withdrawn |
Effective date: 20120330 |